ETV Bharat / city

Natco Pharma to provide Baricitinib tablets to AP

Natco Pharma Limited on behalf of the Natco trust informed AP CM YS Jagan Mohan Reddy that will provide Barinat‌ tablets which are used in the treatment of COVID19 for free, in Andhra Pradesh.

Natco Pharma
Natco Pharma
author img

By

Published : May 22, 2021, 8:19 AM IST

Amaravati (AP): Natco Pharma Limited has written a letter to Chief Minister YS Jagan Mohan Reddy stating that, on behalf of Natco trust, it will provide Baricitinib – 4mg (Barinat‌) tablets which are used in the treatment of COVID for free, in Andhra Pradesh.

The Company has stated that it will provide tablets of market price Rs 4.20 crore to nearly one lakh patients who are being treated in Government hospitals and health institutions.

Read: NIA files chargesheets against seven CPI 'Maoist operatives'

Natco trust Managing trustee VC Nannapaneni said the medicine will be supplied in phases in the next few weeks.

The drug Baricitinib has received restricted emergency use approval from the Central Drugs Standard Control Organization (CDSCO), Ministry of Health, India, for use in combination with Remdesivir for the treatment of suspected or laboratory-confirmed Covid-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

Read: HC sets aside SEC notification on polls to local bodies

Earlier, on May 17, Chief Minister YS Jagan Mohan Reddy held a review meeting on the prevailing Covid-19 situation, vaccination and directed the officials to extend the curfew till May end.

During the meeting held at the CM's camp office, it was decided that the curfew should be extended to a minimum of four weeks to contain the situation and it has been only 10 days since the state has imposed curfew.

Amaravati (AP): Natco Pharma Limited has written a letter to Chief Minister YS Jagan Mohan Reddy stating that, on behalf of Natco trust, it will provide Baricitinib – 4mg (Barinat‌) tablets which are used in the treatment of COVID for free, in Andhra Pradesh.

The Company has stated that it will provide tablets of market price Rs 4.20 crore to nearly one lakh patients who are being treated in Government hospitals and health institutions.

Read: NIA files chargesheets against seven CPI 'Maoist operatives'

Natco trust Managing trustee VC Nannapaneni said the medicine will be supplied in phases in the next few weeks.

The drug Baricitinib has received restricted emergency use approval from the Central Drugs Standard Control Organization (CDSCO), Ministry of Health, India, for use in combination with Remdesivir for the treatment of suspected or laboratory-confirmed Covid-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

Read: HC sets aside SEC notification on polls to local bodies

Earlier, on May 17, Chief Minister YS Jagan Mohan Reddy held a review meeting on the prevailing Covid-19 situation, vaccination and directed the officials to extend the curfew till May end.

During the meeting held at the CM's camp office, it was decided that the curfew should be extended to a minimum of four weeks to contain the situation and it has been only 10 days since the state has imposed curfew.

ETV Bharat Logo

Copyright © 2025 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.